Stock listing
NASDAQ:CGON CG Oncology, Inc. Stock
Home listing (NASDAQ) of CG Oncology, Inc.
Follow CG Oncology, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CGON
$61.96 USD -2.72 (-4.2%)
Close on Nov 2, 2026
- Day range
- $61.01 – $64.68 USDNov 2, 2026
- Volume
- 1.28M sharesNov 2, 2026
- Market cap
- $5.49B USDAt the close on Nov 2, 2026 · price × 88.64M shares outstanding
- 52-week range
- $35.80 – $80.97 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $61.74M USDMedian day 829,900 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CGON · Home | $61.96 USD | -2.72 (-4.2%) | 1,279,526 | $64.18 | $64.68 | $61.01 | $64.68 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:CGON · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $61.96 | -2.72 | -4.2% | $64.18 | $64.68 | $61.01 | 1,279,526 | |
| $64.68 | +1.21 | +1.9% | $63.02 | $65.55 | $60.63 | 870,326 | |
| $63.47 | -0.49 | -0.8% | $64.28 | $65.59 | $63.08 | 782,614 | |
| $63.96 | +1.02 | +1.6% | $62.53 | $64.12 | $62.30 | 944,090 | |
| $62.94 | +1.38 | +2.2% | $61.46 | $64.13 | $59.96 | 709,340 | |
| $61.56 | -0.15 | -0.2% | $61.76 | $62.80 | $61.06 | 880,160 | |
| $61.71 | -0.83 | -1.3% | $62.36 | $62.36 | $59.86 | 1,064,552 | |
| $62.54 | +0.30 | +0.5% | $61.95 | $63.19 | $61.40 | 579,519 | |
| $62.24 | +0.31 | +0.5% | $62.43 | $63.57 | $61.27 | 530,138 | |
| $61.93 | +1.97 | +3.3% | $60.16 | $62.71 | $60.16 | 766,680 | |
| $59.96 | +0.11 | +0.2% | $60.44 | $61.25 | $59.22 | 1,215,168 | |
| $59.85 | -2.01 | -3.2% | $61.86 | $62.00 | $59.37 | 1,079,700 | |
| $61.86 | +0.02 | 0.0% | $62.70 | $63.24 | $60.96 | 1,186,400 | |
| $61.84 | -0.56 | -0.9% | $62.48 | $63.44 | $61.27 | 1,100,400 | |
| $62.40 | -0.73 | -1.2% | $61.92 | $63.85 | $61.52 | 1,188,600 | |
| $63.13 | -0.69 | -1.1% | $63.43 | $64.15 | $62.68 | 660,600 | |
| $63.82 | +0.56 | +0.9% | $62.97 | $65.18 | $62.88 | 516,500 | |
| $63.26 | +0.88 | +1.4% | $61.65 | $63.71 | $61.11 | 910,300 | |
| $62.38 | -1.26 | -2.0% | $62.68 | $63.64 | $61.90 | 621,800 | |
| $63.64 | -5.07 | -7.4% | $69.17 | $69.17 | $63.19 | 774,400 | |
| $68.71 | +1.33 | +2.0% | $67.60 | $68.95 | $65.71 | 788,400 | |
| $67.38 | -0.97 | -1.4% | $69.35 | $69.73 | $66.61 | 1,541,100 | |
| $68.35 | -2.54 | -3.6% | $70.38 | $71.27 | $68.32 | 984,900 | |
| $70.89 | +0.37 | +0.5% | $70.34 | $73.16 | $69.23 | 1,330,900 | |
| $70.52 | +0.91 | +1.3% | $69.56 | $70.68 | $68.26 | 1,035,400 | |
| $69.61 | +2.46 | +3.7% | $66.96 | $69.94 | $66.01 | 1,759,600 | |
| $67.15 | -1.61 | -2.3% | $69.32 | $70.05 | $66.76 | 1,177,500 | |
| $68.76 | -4.60 | -6.3% | $73.10 | $73.44 | $68.15 | 1,444,200 | |
| $73.36 | -4.38 | -5.6% | $76.87 | $77.79 | $71.86 | 830,900 | |
| $77.74 | -0.51 | -0.7% | $78.31 | $80.63 | $76.25 | 1,641,900 | |
| $78.25 | +3.63 | +4.9% | $75.74 | $78.47 | $74.22 | 1,114,900 | |
| $74.62 | -1.00 | -1.3% | $75.87 | $75.87 | $72.82 | 1,779,200 | |
| $75.62 | +1.50 | +2.0% | $75.00 | $76.50 | $74.43 | 894,300 | |
| $74.12 | +1.57 | +2.2% | $72.66 | $74.59 | $72.66 | 795,600 | |
| $72.55 | -1.24 | -1.7% | $74.13 | $74.13 | $72.48 | 1,037,300 | |
| $73.79 | +1.44 | +2.0% | $72.30 | $74.67 | $71.78 | 829,900 | |
| $72.35 | +0.35 | +0.5% | $72.82 | $75.00 | $71.53 | 759,800 | |
| $72.00 | +0.04 | +0.1% | $70.91 | $72.58 | $70.00 | 657,900 | |
| $71.96 | -1.44 | -2.0% | $73.04 | $74.85 | $70.90 | 707,900 | |
| $73.40 | -1.27 | -1.7% | $73.23 | $74.60 | $72.25 | 550,800 | |
| $74.67 | +0.34 | +0.5% | $73.02 | $74.88 | $72.87 | 282,500 | |
| $74.33 | -0.26 | -0.3% | $74.94 | $75.02 | $73.69 | 359,700 | |
| $74.59 | -1.27 | -1.7% | $76.84 | $79.23 | $73.89 | 663,900 | |
| $75.86 | +0.70 | +0.9% | $74.74 | $76.24 | $74.20 | 876,100 | |
| $75.16 | +0.82 | +1.1% | $74.09 | $76.14 | $72.12 | 840,700 | |
| $74.34 | -4.67 | -5.9% | $78.15 | $78.16 | $73.93 | 612,600 | |
| $79.01 | +0.59 | +0.8% | $78.01 | $79.40 | $77.63 | 328,900 | |
| $78.42 | -0.53 | -0.7% | $78.29 | $78.94 | $76.87 | 507,800 | |
| $78.95 | +0.72 | +0.9% | $79.00 | $80.07 | $78.10 | 736,169 | |
| $78.23 | -1.58 | -2.0% | $79.44 | $79.89 | $77.51 | 1,162,618 | |
| $79.81 | +2.20 | +2.8% | $78.69 | $79.89 | $77.38 | 701,700 | |
| $77.61 | -3.07 | -3.8% | $79.50 | $79.71 | $77.17 | 668,000 | |
| $80.68 | +4.39 | +5.8% | $77.80 | $80.97 | $77.00 | 845,800 | |
| $76.29 | -0.82 | -1.1% | $75.83 | $77.50 | $75.31 | 562,500 | |
| $77.11 | +2.08 | +2.8% | $73.87 | $77.42 | $73.87 | 958,300 | |
| $75.03 | +0.32 | +0.4% | $74.54 | $75.66 | $73.50 | 596,300 | |
| $74.71 | -2.28 | -3.0% | $77.25 | $77.48 | $74.58 | 748,800 | |
| $76.99 | -0.04 | -0.1% | $77.50 | $79.39 | $76.21 | 766,100 | |
| $77.03 | +0.47 | +0.6% | $76.68 | $77.49 | $75.34 | 809,612 | |
| $76.56 | +1.46 | +1.9% | $74.64 | $76.59 | $74.57 | 811,295 | |
| $75.10 | +0.25 | +0.3% | $74.97 | $76.20 | $73.51 | 611,600 | |
| $74.85 | +2.43 | +3.4% | $71.85 | $76.50 | $71.85 | 936,000 | |
| $72.42 | +1.02 | +1.4% | $71.47 | $73.82 | $71.26 | 922,700 | |
| $71.40 | +2.25 | +3.3% | $69.62 | $72.64 | $69.62 | 883,300 | |
| $69.15 | -2.04 | -2.9% | $71.29 | $71.29 | $68.08 | 626,100 |
- Ticker
- NASDAQ:CGON
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 13, 2026
CG Oncology Appoints Proven Biopharmaceutical Commercial Leader Isabel Kalofonos as Chief Commercial Officer
Latest deck · Oct 24, 2026
New England Section of the American Urological Association Annual Meeting 2026
Conference · 8 slides
Latest news
CG Oncology Appoints Proven Biopharmaceutical Commercial Leader Isabel Kalofonos as Chief Commercial Officer
Oct 13, 2026
Closed $62.40 (-1.2%) on Oct 13, 2026
CG Oncology to Present at Upcoming Investor Conferences in September
Sep 2, 2026
Closed $74.59 (-1.7%) on Sep 2, 2026
CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates
Aug 6, 2026
Closed $74.85 (+3.4%) on Aug 6, 2026
CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology
Jul 27, 2026
Closed $72.62 (-1.2%) on Jul 28, 2026
CG Oncology to Present at Upcoming Investor Conferences in June
May 28, 2026
Closed $62.29 (+2.6%) on May 29, 2026
SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
May 19, 2026
Closed $63.30 (+0.6%) on May 19, 2026
CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients
May 15, 2026
Closed $66.93 (-3.7%) on May 15, 2026
CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC
May 11, 2026
Closed $72.07 (+4.0%) on May 12, 2026
CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates
May 8, 2026
Closed $69.62 (+0.6%) on May 8, 2026
CG Oncology to Present at Upcoming Investor Conferences in May
May 5, 2026
Closed $67.18 (-0.8%) on May 5, 2026
Decks
New England Section of the American Urological Association Annual Meeting 2026
Conference · 8 slides · Oct 24, 2026
New England Section of the American Urological Association Annual Meeting 2026
Conference · 12 slides · Oct 23, 2026
SUO Annual Meeting at AUA 2026
Conference · 15 slides · May 16, 2026
EAU Annual Meeting (EAU26) 2026
Conference · 8 slides · Mar 16, 2026
CG Oncology, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 59 in all · newest Oct 13, 2026 · oldest 2024
- Decks
- 28 decks · latest Oct 24, 2026
Where CG Oncology, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CGON · Home listing · This page | NASDAQ | United States | USD |
| BOATS:CGON | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about CG Oncology, Inc.